Clover Health Investments (CLOV) Confirms SEC Investigation

February 5, 2021 6:20 AM EST
Get Alerts CLOV Hot Sheet
Price: $7.35 -0.94%

Overall Analyst Rating:
    NEUTRAL (Up Up)

Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Clover Health Investments (NASDAQ: CLOV) said ollowing the publication of an article by Hindenburg Research on February 4, 2021, concerning the recently completed business combination of Clover Health Investments, Corp., the Company received a letter from the Securities and Exchange Commission (the “SEC”) indicating that it is conducting an investigation and requesting document and data preservation for the period from January 1, 2020, to the present, relating to certain matters that are referenced in the article. The Company intends to cooperate with the SEC’s investigation.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation, SPAC, Short Sales, Trader Talk

Related Entities

Hindenburg Research